Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Total Debt (2023 - 2025)

Historic Total Debt for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $988000.0.

  • Onconetix's Total Debt rose 30644.89% to $988000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $988000.0, marking a year-over-year increase of 30644.89%. This contributed to the annual value of $121498.0 for FY2023, which is N/A changed from last year.
  • Onconetix's Total Debt amounted to $988000.0 in Q3 2025, which was up 30644.89% from $243081.0 recorded in Q3 2024.
  • Onconetix's Total Debt's 5-year high stood at $988000.0 during Q3 2025, with a 5-year trough of $10461.0 in Q3 2023.
  • In the last 3 years, Onconetix's Total Debt had a median value of $117699.5 in 2023 and averaged $259932.1.
  • Over the last 5 years, Onconetix's Total Debt had its largest YoY gain of 222368.8% in 2024, and its largest YoY loss of 7610.12% in 2024.
  • Onconetix's Total Debt (Quarter) stood at $121498.0 in 2023, then surged by 100.07% to $243081.0 in 2024, then soared by 306.45% to $988000.0 in 2025.
  • Its last three reported values are $988000.0 in Q3 2025, $243081.0 for Q3 2024, and $113901.0 during Q2 2024.